Congratulations to Zuzana Tothova, MD, PhD who is the recipient of the Doris Duke Foundation’s Paragon Award for Research Excellence! – Dana-Farber Cancer Institute

Dana-Farber Cancer Institute, made the following post on LinkedIn:

“Congratulations to Zuzana Tothova, MD, PhD who is the recipient of the Doris Duke Foundation’s Paragon Award for Research Excellence!

This one-time recognition honors physician-scientists who have significantly advanced knowledge toward the prevention, diagnosis, and treatment of human disease or who have, through their professional contributions, improved the health outcomes of patients.

Tothova’s research is focused on understanding the biology and therapeutic targeting of blood cancers, with a particular focus on the transition from the pre-malignant state of clonal hematopoiesis to myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

‘Receiving the Paragon Award from the Doris Duke Foundation means the world to me. I am extremely honored and very touched by this recognition,’ said Tothova.”

For details click here.
Source: Dana-Farber Cancer Institute/LinkedIn

Since its founding in 1947, Dana-Farber Cancer Institute in Boston, Massachusetts provides adults and children with cancer with the best treatment available today while developing tomorrow’s cures through cutting-edge research. Dana-Farber researchers have contributed to the development of 35 of 75 cancer drugs recently approved by the FDA for use in cancer patients. Providing advanced training in cancer treatment and research for an international faculty, the Institute conducts community-based programs in cancer prevention, detection, and control throughout New England.